Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04419402
Title Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer (ENZA-p)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Indications

prostate adenocarcinoma

prostate cancer

Therapies

Enzalutamide + lutetium Lu 177 vipivotide tetraxetan

Enzalutamide

Age Groups: senior | adult
Covered Countries


No variant requirements are available.